New and developing diagnostic technologies for urinary tract infections.

Area of Science:

• Microbiology
• Infectious Diseases
• Diagnostic Technologies

Background:

• Accurate identification and antimicrobial susceptibility of uropathogens are vital for managing urinary tract infections (UTIs).
• Current methods like urine dipsticks lack diagnostic accuracy, while urine cultures are time-consuming (2-3 days).
• The overuse of empirical antibiotics has led to multidrug-resistant organisms, limiting treatment options and increasing healthcare costs.

Purpose of the Study:

• To highlight the need for novel diagnostic approaches for UTIs.
• To discuss the limitations of current diagnostic methods.
• To explore emerging technologies for rapid pathogen identification and antimicrobial susceptibility testing.

Main Methods:

• Review of current diagnostic practices for UTIs.
• Discussion of limitations of urine dipsticks and urine cultures.
• Exploration of new diagnostic platforms like nucleic acid tests, mass spectrometry, biosensors, and microfluidics.

Main Results:

• Nucleic acid tests and mass spectrometry improve pathogen identification speed and accuracy from primary cultures.
• These technologies currently lack comprehensive antimicrobial susceptibility information when applied directly to urine.
• Emerging technologies show promise for direct urine testing, rapid susceptibility determination, and point-of-care UTI diagnostics.

Conclusions:

• Novel diagnostic platforms are essential to address the challenges posed by multidrug-resistant organisms in UTIs.
• Technologies like biosensors and microfluidics offer potential for direct pathogen detection and rapid antimicrobial susceptibility testing from urine.
• Successful implementation of these advanced diagnostics could lead to precision medicine for improved UTI management and public health.